-
1.发明申请COMBINATION TREATMENTS COMPRISING C-MET ANTAGONISTS AND B-RAF ANTAGONISTS 审中-公开包含C-MET拮抗剂和B-RAF拮抗剂的组合治疗公开(公告)号：US20150125452A1
公开(公告)日：2015-05-07
申请号：US14535071
申请日：2014-11-06
Applicant: GENENTECH, INC.
Inventor： Timothy R. Wilson , Hartmut Koeppen , Mark Merchant , Jeffrey Settleman
IPC: A61K39/395 , G01N33/574 , C12Q1/68 , A61K31/437 , A61K31/4545
CPC classification number: A61K39/3955 , A61K31/437 , A61K31/4439 , A61K31/4545 , A61K45/06 , C07K16/2863 , C07K16/3053 , C07K2317/75 , C12Q1/6886 , C12Q2600/106 , C12Q2600/158 , G01N33/5091 , G01N33/573 , G01N33/5748 , G01N33/57488 , G01N33/57496 , G01N33/6872 , G01N33/74 , G01N2800/52 , A61K2300/00 , A61K39/39558
Abstract: The present invention relates generally to the fields of molecular biology and growth factor regulation. More specifically, the invention relates to therapies for the treatment of pathological conditions, such as cancer.
Abstract translation: 本发明一般涉及分子生物学和生长因子调节领域。 更具体地，本发明涉及用于治疗诸如癌症的病理状况的治疗。
-
公开(公告)号：US20130078252A1
公开(公告)日：2013-03-28
申请号：US13622878
申请日：2012-09-19
Applicant: Genentech, Inc.
Inventor： Timothy R. Wilson , Hartmut Koeppen , Mark Merchant , Jeffrey Settleman
IPC: A61K39/00 , A61K31/437 , A61K39/395 , G01N33/74 , G01N33/573 , A61K31/4545 , A61K31/4439 , C12Q1/68 , G01N33/574
CPC classification number: A61K39/3955 , A61K31/437 , A61K31/4439 , A61K31/4545 , A61K45/06 , C07K16/2863 , C07K16/3053 , C07K2317/75 , C12Q1/6886 , C12Q2600/106 , C12Q2600/158 , G01N33/5091 , G01N33/573 , G01N33/5748 , G01N33/57488 , G01N33/57496 , G01N33/6872 , G01N33/74 , G01N2800/52 , A61K2300/00 , A61K39/39558
Abstract: The present invention relates generally to the fields of molecular biology and growth factor regulation. More specifically, the invention relates to therapies for the treatment of pathological conditions, such as cancer.
-
Search Results
2
records
(took 0.013 seconds)
